MEA Fluoroscopy Market Size (2024 - 2029)

The Middle East and Africa fluoroscopy market is projected to experience growth over the forecast period, driven by factors such as the increasing demand for minimally-invasive surgeries, a growing geriatric population, and the prevalence of chronic diseases. The market's expansion is supported by the rising use of fluoroscopy in various clinical departments beyond traditional imaging settings, due to its advantages in diagnostic and therapeutic procedures. However, challenges such as radiation exposure concerns, the adoption of refurbished systems, and stringent regulations for imaging devices may hinder market growth.

Market Size of MEA Fluoroscopy Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
MEA Fluoroscopy Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 217.04 Million
Market Size (2029) USD 264.43 Million
CAGR (2024 - 2029) 4.03 %
Market Concentration High

Major Players

MEA Fluoroscopy Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Middle East & Africa Fluoroscopy Market Analysis

The MEA Fluoroscopy Market size is estimated at USD 217.04 million in 2024, and is expected to reach USD 264.43 million by 2029, growing at a CAGR of 4.03% during the forecast period (2024-2029).

The COVID-19 pandemic placed enormous pressure on hospitals and healthcare systems that were understaffed and overworked. For instance, an article published in the World Journal of Gastrointestinal Endoscopy in November 2021 reported that as per a survey conducted in Africa, there was a 13% reduction in endoscopic procedures during the beginning of the pandemic. Such a reduction in patient volume impacted the demand for fluoroscopy, significantly affecting the market growth during the pandemic. However, the market returned to a pre-pandemic level as COVID-19 cases declined which led to the normal to high demand levels for therapeutic and diagnostic procedures. For instance, according to an article published by the Saudi Journal of Medical and Pharmaceutical Sciences in February 2022, the COVID-19 pandemic has drastically influenced endoscopic retrograde cholangiopancreatography (a procedure that requires fluoroscopy) practice with an increase in the urgent endoscopic retrograde cholangiopancreatography (ERCP) indications. Hence, the COVID-19 pandemic severely affected the market in the initial stages of the pandemic, but as the COVID-19 cases started to decline, the market saw significant growth.

Factors such as rising demand for minimally-invasive surgeries, growing geriatric population, prevalence of chronic diseases, and advantages associated with fluoroscopy are expected to drive the market growth over the forecast period. For instance, as per the article published by Khaleej Times in November 2022, every year in the UAE, around 8,000 to 10,000 patients suffer from a stroke, equating to about one patient every hour. Such a high frequency of heart diseases is expected to fuel the demand for fluoroscopy thereby boosting the market growth. Furthermore, according to the 2022 statistics published by the United Nations Population Fund, in Egypt, a large proportion of the living population was aged 15-64, accounting for 61% in 2022. In addition, as per the same source, 6% of the population was 65 years and above in 2022. Likewise, as per the World Bank data released in December 2021, around 59.76% of Israel's total population was aged 15 to 64 years, and nearly 12.41% of Israel's total population was 65 years and older. As the geriatric population is prone to suffer from various chronic conditions this is likely to create demand for diagnosis which may contribute to market growth.

Additionally, according to an article published by Pain and Therapy, in February 2021, most interventions used for chronic pain management include fluoroscopy-guided surgeries. Furthermore, according to an article published by Radiation and Environmental Biophysics, in August 2021, in recent years, there has been growing use of X-ray fluoroscopy in clinical departments outside the main imaging departments for clinicians such as interventional cardiologists, electro-physiologists, vascular surgeons, urologists, orthopedic surgeons, and gastroenterologist in the gulf countries. Thus, with the rise in the use of fluoroscopy due to its advantages associated with it, the market is likely to grow over the forecast period.

However, side effects due to radiation exposure, the rising adoption of refurbished systems, and stringent regulations for imaging devices impede the market growth.

Middle East & Africa Fluoroscopy Industry Segmentation

As per the scope of the report, fluoroscopy refers to an imaging technique that uses X-rays to produce real-time images of internal organs. Unlike X-ray images, which are fixed still images on film, fluoroscopy produces live moving pictures of internal organs, which can be viewed by the naked eye on a digital monitor. A typical fluoroscope has four components, which include an X-ray source, an X-ray image intensifier, an imaging system, and a workstation. The Middle East and Africa Fluoroscopy Market is Segmented by Device Type (Fixed Fluoroscopes, and Mobile Fluoroscopes), Application (Orthopedic, Cardiovascular, Pain Management, Trauma, Neurology, Gastrointestinal, Urology, General Surgery, and Other Applications), and Geography (GCC, South Africa, Rest of the Middle East and Africa). The report offers the value (in USD million) for the above segments.

By Device Type
Fixed Fluoroscopes
Mobile Fluoroscopes
By Application
Orthopedic
Cardiovascular
Pain Management and Trauma
Neurology
Gastrointestinal
Urology
General Surgery
Other Applications
Geography
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
Need A Different Region Or Segment?
Customize Now

MEA Fluoroscopy Market Size Summary

The Middle East and Africa fluoroscopy market is poised for growth, driven by factors such as the increasing demand for minimally invasive surgeries, a growing geriatric population, and the rising prevalence of chronic diseases. The market experienced a temporary setback during the COVID-19 pandemic due to reduced patient volumes and procedural delays. However, it rebounded as demand for diagnostic and therapeutic procedures returned to pre-pandemic levels. The market's expansion is further supported by the growing use of fluoroscopy in various medical fields, including interventional cardiology and orthopedic surgery, as well as its application in chronic pain management. Despite challenges such as radiation exposure concerns and stringent regulations, the market is expected to benefit from advancements in healthcare infrastructure and increased government spending on health services.

The cardiovascular segment is anticipated to see significant growth, fueled by the high prevalence of cardiovascular diseases in the region and the associated risk factors such as hypertension. The Gulf Cooperation Council countries are also contributing to market expansion through strategic initiatives and product launches. The rising obesity rates, particularly in the UAE, are expected to drive the demand for fluoroscopy, especially in imaging post-gastric bypass patients. The market is characterized by a consolidated competitive landscape, with key players like GE Healthcare, Canon Medical Systems, and Siemens Healthineers leading the charge. Strategic partnerships and acquisitions, such as Ibnsina Pharma's acquisition of EI Shorouk Hospital, are further propelling market growth by enhancing healthcare service offerings and technological capabilities.

Explore More

MEA Fluoroscopy Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Demand for Minimally-invasive Surgeries

      2. 1.2.2 Growing Geriatric Population and Prevalence of Chronic Diseases

      3. 1.2.3 Advantages Associated With Fluoroscopy

    3. 1.3 Market Restraints

      1. 1.3.1 Side Effects due to Radiation Exposure

      2. 1.3.2 Rising Adoption of Refurbished Systems

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Device Type

      1. 2.1.1 Fixed Fluoroscopes

      2. 2.1.2 Mobile Fluoroscopes

    2. 2.2 By Application

      1. 2.2.1 Orthopedic

      2. 2.2.2 Cardiovascular

      3. 2.2.3 Pain Management and Trauma

      4. 2.2.4 Neurology

      5. 2.2.5 Gastrointestinal

      6. 2.2.6 Urology

      7. 2.2.7 General Surgery

      8. 2.2.8 Other Applications

    3. 2.3 Geography

      1. 2.3.1 Middle-East & Africa

        1. 2.3.1.1 GCC

        2. 2.3.1.2 South Africa

        3. 2.3.1.3 Rest of Middle-East & Africa

MEA Fluoroscopy Market Size FAQs

The MEA Fluoroscopy Market size is expected to reach USD 217.04 million in 2024 and grow at a CAGR of 4.03% to reach USD 264.43 million by 2029.

In 2024, the MEA Fluoroscopy Market size is expected to reach USD 217.04 million.

Middle East & Africa Fluoroscopy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)